Flagpost is a blog on current issues of interest to members of the Australian Parliament
The landmark decision of the US Supreme Court in the Association for Molecular Pathology v Myriad Genetics case would appear to have overturned three decades of gene patent awards, signaling a clear shift from the Patent and Trademark Office’s past practice.Nearly 20 years ago, Myriad obtained several patents after discovering the precise location and sequence of the BRCA1 and BRCA2 genes, mutations of which can dramatically increase the risk of breast and ovarian cancer. This knowledge enabled Myriad to develop medical tests for detecting mutations in these genes to assess a patient’s cancer risk.The validity of the patents was challenged by a consortium of interested parties. Cancer p... Read more...
Please access the survey at: